That same year, Zafgen demonstrated beloranibs efficacy, a MetAP2 inhibitor, in a Phase III trial, but safety concerns ultimately led to its discontinuation
Certainly, there are people who have been identified with L-carnitine deficiency, often due to transporter issues (difficulty getting L-carnitine into cells, or absorbing it from the diet)
1 Beaumont Hospital, Dublin 9, Ireland
Le-Vel may conduct internal studies, but these rarely receive peer review or publication in scientific journals
Track your body weight changes, blood sugar levels (if applicable), and any adverse events, and discuss them with your healthcare professional during follow-ups